{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:32:00Z","timestamp":1793226720579,"version":"4.5.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.aohep.2026.102433","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:56:40Z","timestamp":1788620200000},"page":"102433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD38 in hepatic pathobiology: mechanisms, disease association and therapeutic implications"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8219-2290","authenticated-orcid":false,"given":"Jason W.","family":"Eng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-3579","authenticated-orcid":false,"given":"Blake R.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvester","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0001","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2353\/ajpath.2007.051212","article-title":"Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule","volume":"170","author":"March","year":"2007","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.aohep.2026.102433_bib0002","doi-asserted-by":"crossref","first-page":"496","DOI":"10.14348\/molcells.2023.0045","article-title":"CD38 Inhibition protects fructose-induced toxicity in primary hepatocytes","volume":"46","author":"Lee","year":"2023","journal-title":"Mol Cells"},{"key":"10.1016\/j.aohep.2026.102433_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102514","article-title":"The calcium signaling enzyme CD38 - a paradigm for membrane topology defining distinct protein functions","volume":"101","author":"Lee","year":"2022","journal-title":"Cell Calcium"},{"issue":"11\u201312","key":"10.1016\/j.aohep.2026.102433_bib0004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2119\/2006-00086.Lee","article-title":"Structure and enzymatic functions of human CD38","volume":"12","author":"Lee","year":"2006","journal-title":"Mol Med"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0005","doi-asserted-by":"crossref","first-page":"C521","DOI":"10.1152\/ajpcell.00451.2021","article-title":"The CD38 glycohydrolase and the NAD sink: implications for pathological conditions","volume":"322","author":"Zeidler","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"10.1016\/j.aohep.2026.102433_bib0006","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","article-title":"CD38 Dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism","volume":"23","author":"Camacho-Pereira","year":"2016","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.aohep.2026.102433_bib0007","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.bbamcr.2014.10.028","article-title":"Determinants of the membrane orientation of a calcium signaling enzyme CD38","volume":"1853","author":"Zhao","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-025-07897-0","article-title":"ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth","volume":"8","author":"Guo","year":"2025","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0009","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1074\/jbc.275.3.1685","article-title":"Direct interaction of the CD38 cytoplasmic tail and the Lck SH2 domain. Cd38 transduces T cell activation signals through associated Lck","volume":"275","author":"Cho","year":"2000","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.aohep.2026.102433_bib0010","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.4049\/jimmunol.179.11.7827","article-title":"Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by adp-ribose, the major product generated by the CD38 enzyme reaction","volume":"179","author":"Partida-Sanchez","year":"2007","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.aohep.2026.102433_bib0011","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood-2004-10-3873","article-title":"CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival","volume":"105","author":"Deaglio","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.aohep.2026.102433_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1486948","article-title":"Daratumumab induces CD38 internalization and impairs myeloma cell adhesion","volume":"7","author":"Ghose","year":"2018","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.aohep.2026.102433_bib0013","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2005-07-2913","article-title":"CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells","volume":"107","author":"Frasca","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0014","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1096\/fj.00-0522fje","article-title":"Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway","volume":"15","author":"Deaglio","year":"2001","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.aohep.2026.102433_bib0015","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s42255-020-00305-3","article-title":"Senescent cells promote tissue NAD(+) decline during ageing via the activation of CD38(+) macrophages","volume":"2","author":"Covarrubias","year":"2020","journal-title":"Nat Metab"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0016","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cmet.2018.03.018","article-title":"Quantitative analysis of NAD synthesis-breakdown fluxes","volume":"27","author":"Liu","year":"2018","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.aohep.2026.102433_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040309","article-title":"The CD39\/CD73\/adenosine and NAD\/CD38\/CD203a\/CD73 axis in cutaneous T-cell lymphomas","volume":"14","author":"Lin","year":"2025","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.aohep.2026.102433_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071212","article-title":"Contribution of NADPH oxidase to membrane CD38 internalization and activation in coronary arterial myocytes","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.aohep.2026.102433_bib0019","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1074\/jbc.RA118.002113","article-title":"CD38 produces nicotinic acid adenosine dinucleotide phosphate in the lysosome","volume":"293","author":"Fang","year":"2018","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.aohep.2026.102433_bib0020","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ceca.2010.05.001","article-title":"Two-pore channels: regulation by NAADP and customized roles in triggering calcium signals","volume":"47","author":"Patel","year":"2010","journal-title":"Cell Calcium"},{"issue":"12","key":"10.1016\/j.aohep.2026.102433_bib0021","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/jcmm.12173","article-title":"Autophagy maturation associated with CD38-mediated regulation of lysosome function in mouse glomerular podocytes","volume":"17","author":"Xiong","year":"2013","journal-title":"J Cell Mol Med"},{"issue":"9","key":"10.1016\/j.aohep.2026.102433_bib0022","doi-asserted-by":"crossref","first-page":"12565","DOI":"10.1096\/fj.202001249R","article-title":"Interleukin-8 drives CD38 to form NAADP from NADP(+) and NAAD in the endolysosomes to mobilize Ca(2+) and effect cell migration","volume":"34","author":"Nam","year":"2020","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0023","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/15548627.2021.1954779","article-title":"LRRK2 is required for CD38-mediated NAADP-Ca(2+) signaling and the downstream activation of TFEB (transcription factor EB) in immune cells","volume":"18","author":"Nabar","year":"2022","journal-title":"Autophagy"},{"issue":"52","key":"10.1016\/j.aohep.2026.102433_bib0024","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.REV119.009635","article-title":"Resolving the topological enigma in Ca(2+) signaling by cyclic ADP-ribose and NAADP","volume":"294","author":"Lee","year":"2019","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.aohep.2026.102433_bib0025","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1074\/jbc.RA118.005844","article-title":"A cytosolic chaperone complex controls folding and degradation of type III CD38","volume":"294","author":"Wu","year":"2019","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.aohep.2026.102433_bib0026","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2007.07.035","article-title":"Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival","volume":"130","author":"Yang","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0027","article-title":"NAD(+) metabolism, stemness, the immune response, and cancer","volume":"6","author":"Navas","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"31","key":"10.1016\/j.aohep.2026.102433_bib0028","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1073\/pnas.1703718114","article-title":"Cytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levels","volume":"114","author":"Liu","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0029","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ceca.2015.05.005","article-title":"Both RyRs and TPCs are required for NAADP-induced intracellular Ca(2)(+) release","volume":"58","author":"Gerasimenko","year":"2015","journal-title":"Cell Calcium"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/biom13050759","article-title":"Bidirectional TRP\/L type Ca(2+) channel\/RyR\/BK(Ca) molecular and functional signaloplex in vascular smooth muscles","volume":"13","author":"Dryn","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0031","doi-asserted-by":"crossref","first-page":"C297","DOI":"10.1152\/ajpcell.00139.2017","article-title":"Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion","volume":"314","author":"Boslett","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0032","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1096\/fj.201800235R","article-title":"Oxidative activation of type III CD38 by NADPH oxidase-derived hydrogen peroxide in Ca(2+) signaling","volume":"33","author":"Park","year":"2019","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.aohep.2026.102433_bib0033","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jphs.2025.05.013","article-title":"Targeting CD38 to alleviate brain endothelial cell dysfunction and cognitive impairment in vascular dementia","volume":"158","author":"Yu","year":"2025","journal-title":"J Pharmacol Sci"},{"issue":"11","key":"10.1016\/j.aohep.2026.102433_bib0034","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/intimm\/8.11.1643","article-title":"Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids","volume":"8","author":"Funaro","year":"1996","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2567.2008.02914.x","article-title":"Soluble CD38 significantly prolongs the lifespan of memory B-cell responses","volume":"125","author":"Liu","year":"2008","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0036","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1073\/pnas.1413493112","article-title":"Seminal CD38 is a pivotal regulator for fetomaternal tolerance","volume":"112","author":"Kim","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7836","key":"10.1016\/j.aohep.2026.102433_bib0037","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-020-2741-7","article-title":"SLC25A51 is a mammalian mitochondrial NAD+ transporter","volume":"588","author":"Luongo","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0038","article-title":"CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice","volume":"6","author":"Gan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0039","article-title":"NAD(+) exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1165\/rcmb.2014-0141OC","article-title":"CD38 mediates angiotensin II-induced intracellular Ca(2+) release in rat pulmonary arterial smooth muscle cells","volume":"52","author":"Lee","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"27","key":"10.1016\/j.aohep.2026.102433_bib0041","doi-asserted-by":"crossref","first-page":"15922","DOI":"10.1074\/jbc.271.27.15922","article-title":"Post-translational modification of CD38 protein into a high molecular weight form alters its catalytic properties","volume":"271","author":"Umar","year":"1996","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0042","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-014-0107-0","article-title":"MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN\/AKT in human airway smooth muscle cells","volume":"15","author":"Dileepan","year":"2014","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.aohep.2026.102433_bib0043","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.aohep.2026.102433_bib0044","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1124\/dmd.120.000139","article-title":"Cell type-specific roles of CD38 in the interactions of Isoniazid with NAD(+) in the liver","volume":"48","author":"Zhu","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"15","key":"10.1016\/j.aohep.2026.102433_bib0045","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.7150\/ijbs.65588","article-title":"CD38 Deficiency protects mice from high fat diet-induced nonalcoholic fatty liver disease through activating NAD(+)\/sirtuins signaling pathways-mediated inhibition of lipid accumulation and oxidative stress in hepatocytes","volume":"17","author":"Xie","year":"2021","journal-title":"Int J Biol Sci"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0046","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2012.03.002","article-title":"Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity","volume":"15","author":"Ozcan","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2026.102433_bib0047","doi-asserted-by":"crossref","DOI":"10.1038\/srep09482","article-title":"ADP-ribose\/TRPM2-mediated Ca2+ signaling is essential for cytolytic degranulation and antitumor activity of natural killer cells","volume":"5","author":"Rah","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.aohep.2026.102433_bib0048","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s12276-023-01034-9","article-title":"CD38\/ADP-ribose\/TRPM2-mediated nuclear Ca(2+) signaling is essential for hepatic gluconeogenesis in fasting and diabetes","volume":"55","author":"Rah","year":"2023","journal-title":"Exp Mol Med"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0049","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cmet.2018.03.016","article-title":"A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD(+) decline","volume":"27","author":"Tarrago","year":"2018","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.aohep.2026.102433_bib0050","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70147","article-title":"CD38-Targeting peptide vaccine ameliorates aging-associated phenotypes in mice","volume":"24","author":"Yu","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.aohep.2026.102433_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.597959","article-title":"CD38: an immunomodulatory molecule in inflammation and autoimmunity","volume":"11","author":"Piedra-Quintero","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.aohep.2026.102433_bib0052","article-title":"Release of acidic store calcium is required for effective priming of the NLRP3 inflammasome","volume":"2022","author":"Platt","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.aohep.2026.102433_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00760","article-title":"CD38 in adenosinergic pathways and metabolic re-programming in Human multiple myeloma cells: in-tandem insights from basic science to therapy","volume":"10","author":"Horenstein","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.04.009","article-title":"Inflammation in alcohol-associated Hepatitis: pathogenesis and therapeutic targets","volume":"18","author":"Feng","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0055","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiae085","article-title":"Comprehensive analysis of immune signatures in primary biliary cholangitis and autoimmune hepatitis","volume":"117","author":"Yang","year":"2024","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.aohep.2026.102433_bib0056","article-title":"Diagnostic and prognostic biomarkers in autoimmune hepatitis-associated cirrhosis: insights into TBil, CD38, IL-22, TSP-1, GAL-3, and cyc-C","volume":"12","author":"Shi","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0057","article-title":"IL-15-activated CD38(+)HLA-DR(+)CD8(+) T cells induce liver injury in cirrhosis via JAK\/STAT5 and PI3K\/mTOR pathways","volume":"15","author":"Liu","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0058","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.24757","article-title":"Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis","volume":"55","author":"Takahashi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2026.102433_bib0059","first-page":"1","article-title":"CD19(+)CD24(hi)CD38(hi) B cell dysfunction in primary biliary cholangitis","volume":"2020","author":"Chen","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"10308","key":"10.1016\/j.aohep.2026.102433_bib0060","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.aohep.2026.102433_bib0061","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1016\/j.ymthe.2025.04.039","article-title":"CD38(hi) macrophages promote fibrotic transition following acute kidney injury by modulating NAD(+) metabolism","volume":"33","author":"Yao","year":"2025","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101902","article-title":"Targeting CD38-dependent NAD(+) metabolism to mitigate multiple organ fibrosis","volume":"24","author":"Shi","year":"2021","journal-title":"iScience"},{"issue":"S1","key":"10.1016\/j.aohep.2026.102433_bib0063","article-title":"Cellular NAD+, fibroblast senescence and pulmonary fibrosis","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.aohep.2026.102433_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166642","article-title":"Senescent cardiac fibroblasts: a key role in cardiac fibrosis","volume":"1869","author":"Osorio","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"10.1016\/j.aohep.2026.102433_bib0065","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1478-3231.2005.01173.x","article-title":"Altered CD38 expression in thioacetamide-induced rat model of liver cirrhosis","volume":"25","author":"Gan","year":"2005","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.aohep.2026.102433_bib0066","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134927","article-title":"Genetic ablation of CD38 protects against western diet-induced exercise intolerance and metabolic inflexibility","volume":"10","author":"Chiang","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.aohep.2026.102433_bib0067","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cmet.2024.04.020","article-title":"Myocardial infarction accelerates the progression of MASH by triggering immunoinflammatory response and induction of periostin","volume":"36","author":"Xie","year":"2024","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0068","article-title":"Cardiomyocyte specific CD38 deletion protects heart from acute myocardial infarction by activating Sirt3 signaling pathway","volume":"15","author":"Wen","year":"2025","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.aohep.2026.102433_bib0069","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1172\/JCI46243","article-title":"Hepatic Sirt1 deficiency in mice impairs mTorc2\/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance","volume":"121","author":"Wang","year":"2011","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0070","doi-asserted-by":"crossref","first-page":"C776","DOI":"10.1152\/ajpcell.00946.2024","article-title":"Increasing cellular NAD(+) protects hepatocytes against palmitate-induced lipotoxicity by preventing PARP-1 inhibition and the mTORC1-p300 pathway activation","volume":"328","author":"Guo","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0071","article-title":"CD38 downregulation modulates NAD(+) and NADP(H) levels in thermogenic adipose tissues","volume":"1866","author":"Benzi","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"2","key":"10.1016\/j.aohep.2026.102433_bib0072","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16003","article-title":"Acute and acute-on-chronic liver failure: pathogenesis, management and perspectives","volume":"45","author":"Trebicka","year":"2025","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.aohep.2026.102433_bib0073","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jss.2015.11.029","article-title":"Blocking NAD(+)\/CD38\/cADPR\/Ca(2+) pathway in sepsis prevents organ damage","volume":"201","author":"Peng","year":"2016","journal-title":"J Surg Res"},{"issue":"10","key":"10.1016\/j.aohep.2026.102433_bib0074","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fernandez","year":"2018","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.aohep.2026.102433_bib0075","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1096\/fj.201601290R","article-title":"NAADP-mediated Ca(2+) signaling promotes autophagy and protects against LPS-induced liver injury","volume":"31","author":"Rah","year":"2017","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0076","first-page":"25","article-title":"Galactosamine-induced cell death in primary cultures of rat hepatocytes","volume":"100","author":"Schanne","year":"1980","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0077","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-06661-0","article-title":"Extracellular NAD(+) response to post-hepatectomy liver failure: bridging preclinical and clinical findings","volume":"7","author":"Kamali","year":"2024","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0078","first-page":"555","article-title":"Nicotinamide induces liver regeneration and improves liver function by activating SIRT1","volume":"19","author":"Wan","year":"2019","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0079","doi-asserted-by":"crossref","first-page":"G97","DOI":"10.1152\/ajpgi.00093.2017","article-title":"Live cell imaging of cytosolic NADH\/NAD(+) ratio in hepatocytes and liver slices","volume":"314","author":"Masia","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cmet.2023.11.010","article-title":"ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits","volume":"36","author":"Singh","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2026.102433_bib0081","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2022.04.079","article-title":"Inhibition of NAD kinase elevates the hepatic NAD(+) pool and alleviates acetaminophen-induced acute liver injury in mice","volume":"612","author":"Liao","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.aohep.2026.102433_bib0082","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/hep.28912","article-title":"Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration","volume":"65","author":"Mukherjee","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0083","article-title":"Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia\/reperfusion injury","volume":"10","author":"Zhao","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.aohep.2026.102433_bib0084","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1182016","article-title":"CD38 marks the exhausted CD8(+) tissue-resident memory T cells in hepatocellular carcinoma","volume":"14","author":"Reolo","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/HEP.0000000000000804","article-title":"Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature","volume":"80","author":"Engelskircher","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0086","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2152635","article-title":"Overcoming the resistance of hepatocellular carcinoma to PD-1\/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles","volume":"12","author":"Deng","year":"2023","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.aohep.2026.102433_bib0087","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000987","article-title":"Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1\/PD-L1 immunotherapy in hepatocellular carcinoma","volume":"8","author":"Ng","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.aohep.2026.102433_bib0088","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ccell.2014.10.002","article-title":"Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage","volume":"26","author":"Tummala","year":"2014","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.aohep.2026.102433_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101351","article-title":"An NAD(+)-dependent deacetylase SIRT7 promotes HCC development through deacetylation of USP39","volume":"23","author":"Dong","year":"2020","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.aohep.2026.102433_bib0090","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1007\/s12072-023-10544-7","article-title":"Targeting NAD(+) metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression","volume":"17","author":"Sun","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2026.102433_bib0091","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1519300","article-title":"Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects","volume":"16","author":"Horenstein","year":"2025","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0092","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1158\/0008-5472.CAN-24-0400","article-title":"Accumulation of CD38 in hybrid epithelial\/mesenchymal cells promotes immune remodeling and metastasis in breast cancer","volume":"85","author":"Visal","year":"2025","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.aohep.2026.102433_bib0093","first-page":"6007","article-title":"ImmunoPET imaging of CD38 expression in hepatocellular carcinoma using (64)Cu-labeled daratumumab","volume":"11","author":"Li","year":"2019","journal-title":"Am J Transl Res"},{"issue":"3_suppl","key":"10.1016\/j.aohep.2026.102433_bib0094","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.3_suppl.LBA432","article-title":"EMERALD-1: a phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization","volume":"42","author":"Lencioni","year":"2024","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100562","article-title":"Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I\/II, open-label, multicenter study","volume":"7","author":"Simonelli","year":"2022","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.aohep.2026.102433_bib0096","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of Felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0097","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies","volume":"31","author":"Diebold","year":"2025","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0098","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003505","article-title":"Daratumumab for antibody-mediated rejection in heart transplant-A novel therapy: successful treatment of antibody-mediated rejection","volume":"105","author":"Aguilera Agudo","year":"2021","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.aohep.2026.102433_bib0099","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.healun.2024.02.069","article-title":"CD38 Antibody daratumumab as an add-on rescue therapy for AMR - first report in clinical lung transplantation","volume":"43","author":"Hillebrand","year":"2024","journal-title":"J Heart Lung Transplant"},{"issue":"13","key":"10.1016\/j.aohep.2026.102433_bib0100","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","article-title":"Targeting CD38 with Daratumumab monotherapy in multiple myeloma","volume":"373","author":"Lokhorst","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.aohep.2026.102433_bib0101","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-18-1597","article-title":"The mechanism of action of the Anti-CD38 monoclonal antibody isatuximab in multiple myeloma","volume":"25","author":"Moreno","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.aohep.2026.102433_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2021.100639","article-title":"Extended criteria grafts and emerging therapeutics strategy in liver transplantation. The unstable balance between damage and repair","volume":"35","author":"Ghinolfi","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.aohep.2026.102433_bib0103","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7410257","article-title":"CD38 Deficiency protects the heart from ischemia\/reperfusion injury through activating SIRT1\/FOXOs-mediated antioxidative stress pathway","volume":"2016","author":"Guan","year":"2016","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"10.1016\/j.aohep.2026.102433_bib0104","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.21037\/jtd-23-725","article-title":"The role of CD38 in ischemia reperfusion injury in cardiopulmonary bypass and thoracic transplantation: a narrative review","volume":"15","author":"Gouchoe","year":"2023","journal-title":"J Thorac Dis"},{"issue":"11","key":"10.1016\/j.aohep.2026.102433_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06221-0","article-title":"SIRT1 regulates hepatocyte programmed cell death via GSDME - IL18 axis in human and mouse liver transplantation","volume":"14","author":"Kadono","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.aohep.2026.102433_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110294","article-title":"NAMPT inhibition reduces macrophage inflammation through the NAD+\/PARP1 pathway to attenuate liver ischemia-reperfusion injury","volume":"369","author":"Lu","year":"2023","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.aohep.2026.102433_bib0107","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1129413","article-title":"The eNAMPT\/TLR4 inflammatory cascade drives the severity of intra-amniotic inflammation in pregnancy and predicts infant outcomes","volume":"14","author":"Ahmed","year":"2023","journal-title":"Front Physiol"},{"issue":"9","key":"10.1016\/j.aohep.2026.102433_bib0108","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.str.2005.05.012","article-title":"Crystal structure of human CD38 extracellular domain","volume":"13","author":"Liu","year":"2005","journal-title":"Structure"},{"issue":"8","key":"10.1016\/j.aohep.2026.102433_bib0109","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1021\/jm502009h","article-title":"Discovery, synthesis, and biological evaluation of Thiazoloquin(az)olin(on)es as potent CD38 inhibitors","volume":"58","author":"Haffner","year":"2015","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0110","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1016\/S2352-3026(19)30249-2","article-title":"MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial","volume":"7","author":"Raab","year":"2020","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102433_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2024.100043","article-title":"Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed\/refractory multiple myeloma","volume":"1","author":"Krishnan","year":"2024","journal-title":"Blood Neoplasia"},{"issue":"23","key":"10.1016\/j.aohep.2026.102433_bib0112","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa2400409","article-title":"A novel anti-CD38 monoclonal antibody for treating immune thrombocytopenia","volume":"390","author":"Chen","year":"2024","journal-title":"N Engl J Med"},{"issue":"Supplement 1","key":"10.1016\/j.aohep.2026.102433_bib0113","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2025-3035","article-title":"A dose-escalation and safety study of CID-103 followed by a randomized, open-label, parallel-arm multi-dose study evaluating the efficacy and tolerability of CID-103 in adults with persistent or chronic immune thrombocytopenia","volume":"146","author":"Yunfei","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.aohep.2026.102433_bib0114","doi-asserted-by":"crossref","first-page":"S1428","DOI":"10.1016\/j.annonc.2024.10.084","article-title":"63P A randomised, double-blind, phase I study to compare the pharmacokinetics, safety, tolerability, and immunogenicity of HLX15 and daratumumab in healthy male participants","volume":"35","author":"Su","year":"2024","journal-title":"Ann Oncol"},{"issue":"Supplement 1","key":"10.1016\/j.aohep.2026.102433_bib0115","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2023-179504","article-title":"GEN3014 (HexaBody \u00ae-CD38) in Anti-CD38 mab-naive patients with relapsed\/refractory multiple myeloma: preliminary results from a dose-expansion cohort of a phase 1\/2 trial","volume":"142","author":"Grosicki","year":"2023","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.aohep.2026.102433_bib0116","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1158\/1078-0432.CCR-18-2752","article-title":"Targeting multiple myeloma with AMG 424, a novel Anti-CD38\/CD3 bispecific T-cell-recruiting antibody optimized for cytotoxicity and cytokine release","volume":"25","author":"Zuch de Zafra","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0117","first-page":"260","article-title":"Preclinical characterization of ISB 1342, a CD38 x CD3 T-cell engager for relapsed\/refractory multiple myeloma","volume":"142","author":"Pouleau","year":"2023","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.aohep.2026.102433_bib0118","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-194830","article-title":"A CD38xCD28 costimulatory bispecific antibody demonstrates potent preclinical combinatorial activity with a BCMAxCD3 T cell-engager","volume":"144","author":"Olson","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0119","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46310-y","article-title":"Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma","volume":"15","author":"Grandclement","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.aohep.2026.102433_bib0120","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3324\/haematol.2015.137620","article-title":"Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma","volume":"101","author":"Drent","year":"2016","journal-title":"Haematologica"},{"issue":"27","key":"10.1016\/j.aohep.2026.102433_bib0121","article-title":"CD38-Specific CAR integrated into CD38 locus driven by different promoters causes distinct antitumor activities of T and NK cells","volume":"10","author":"Liao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"10.1016\/j.aohep.2026.102433_bib0122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230307","article-title":"Characterization of the immune cell landscape of patients with NAFLD","volume":"15","author":"Diedrich","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2026.102433_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108852","article-title":"A mouse model of the regression of alcoholic hepatitis: monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD(+) metabolism upon alcohol withdrawal","volume":"99","author":"Kang","year":"2022","journal-title":"J Nutr Biochem"},{"issue":"1","key":"10.1016\/j.aohep.2026.102433_bib0124","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jhep.2023.02.035","article-title":"Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B","volume":"79","author":"Montali","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2026.102433_bib0125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.acthis.2008.04.008","article-title":"The predictive value of CD38 positive hepatic stellate cell count for assessing disease activity and fibrosis in patients with chronic hepatitis","volume":"111","author":"Abdeen","year":"2009","journal-title":"Acta Histochem"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812600253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526812600253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:37:33Z","timestamp":1793223453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526812600253X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S166526812600253X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102433","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD38 in hepatic pathobiology: mechanisms, disease association and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102433"}}